Human papillomavirus genotype as a major determinant of the course of cervical cancer

Journal of Clinical Oncology

Volumn 16, Issue 8, 1998, Pages 2613-2619

  Lombard, Isabelle ^a   Vincent Salomon, Anne ^a   Validire, Pierre ^a   Zafrani, Brigitte ^a   de la Rochefordière, Anne ^a   Clough, Krishna ^a   Favre, Michel ^a   Pouillart, Pierre ^a   Sastre Garau, Xavier ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; DISEASE COURSE; FEMALE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING; UTERINE CERVIX CANCER; VIRUS TYPING;

EID: 0031927311     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.8.2613     Document Type: Article

References (46)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606, 1993
2. Rotkin ID: A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 33:1353-1367, 1973
3. Meisels A, Fortin R, Roy M: Condylomatous lesions of the cervix and vagina. Acta Cytol 21:379-390, 1977
4. Orth G, Favre M: Human papillomaviruses: Biochemical and biological properties. Clin Dermatol 3:56-63, 1985
5. Dürst M, Gissman L, Ikenberg H, et al: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80:3812-3815, 1983
6. Bergeron C, Barrasso R, Beaudenon S, et al: Human papillomaviruses associated with cervical intraepithelial neoplasia. Great diversity and distinct distribution in low- and high-grade lesions. Am J Surg Pathol 16:641-649, 1992
7. Bosh FX, Manos M, Munoz N, et al: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Nat Cancer Inst 87:796-802, 1995
8. zur Hausen H: Papillomavirus infections - A major cause of human cancers. Biochim Biophys Acta 1288:F55-F78, 1996
9. Shirasawa H, Tomita Y, Sekiya S, et al: Integration and transcription of human papillomavirus type 16 and 18 sequences in cell lines derived from cervical cancer. J Gen Virol 68:583-591, 1987
10. Crook T, Morgenstern JP, Crawforf L, et al: Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transfected by HPV-16 plus EJ-ras. EMBO J 8:513-519, 1997
11. Wu T-C: Immunology of the human papilloma virus in relation to cancer. Curr Opin Immunol 6:746-754, 1994
12. Lörincz AT, Reid R, Jenson B, et al: Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337, 1992
13. Burger RA, Monk BJ, Kurosaki T, et al: Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer. J Nat Cancer Inst 88:1361-1368, 1996
14. Burnett AF, Barnes WA, Johnson JC, et al: Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer. Gynecol Oncol 47:343-347, 1992
15. Zhang J, Rose B, Thompson CH, et al: Association between oncogenic human papillomaviruses and local invasive patterns in cervical cancer. Gynecol Oncol 57:170-177, 1995
16. Rose BR, Thompson CH, Simpson JM, et al: Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18. Am J Obstet Gynecol 173:1461-1468, 1995
17. Ip EW, Collins R, Srivastava G, et al: Human papillomavirus and its prognostic significance in invasive carcinoma of the cervix in young patients. Int J Gynecol Pathol 11:258-265, 1992
18. Ikenberg H, Sauerbrei W, Schottmüller U, et al: Human papillomavirus DNA in cervical carcinoma - Correlation with clinical data and influence on prognosis. Int J Cancer 59:322-326, 1994
19. Higgins GD, Davy M, Roder D, et al: Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910-913, 1991
20. Kristensen GB, Karlsen F, Jenkins A, et al: Human papillomavirus has no prognostic significance in cervical carcinoma. Euro J Cancer 32A:1349-1353, 1996
21. Riou G, Favre M, Jeannel D, et al: Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171-1174, 1990
22. Vincent-Salomon A, de la Rochefordière A, Salmon R, et al: Frequent association of human papillomavirus 16 and 18 DNA with anal squamous cell and basaloid carcinoma. Mod Pathol 9:614-620, 1996
23. Kawashima M, Favre M, Obaleck S, et al: Premalignant lesions and cancers of the skin in the general population: Evaluation of the role of human papillomaviruses. J Invest Dermatol 95:537-542, 1990
24. Naghashfar ZS, Rosenshein NB, Lorincz AT, et al: Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J Gen Virol 68:3073-3079, 1987
25. Lörincz A, Temple G, Kurman R, et al: Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Nat Cancer Inst 79:671-676, 1987
26. Platz C, Benda J: Female genital tract cancer. Histology of cancer incidence and prognosis: SEER population-based data, 1973-1987. Cancer 75:270-294, 1995
27. Walker J, Bloss JD, Liao S-Y, et al: Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 74:781-785, 1989
28. Rose BR, Thompson CH, Cossart YE, et al: Papillomavirus DNA and prognosis in cervical cancer. Lancet 337:489, 1991
29. Kurman RJ, Schiffmann MH, Lancaster WD, et al: Analysis of individual papillomavirus types in cervical neoplasia: A possible role for HPV18 in rapid progression. Am J Obstet Gynecol 159:293-296, 1988
30. King LA, Tase T, Twiggs LB, et al: Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix. Cancer 63:897-900, 1989
31. DeBritton R, Hildesheim A, De Lao S, et al: Human papillomaviruses and other influences on survival from cervical cancer in Panama. Obstet Gynecol 81:19-24, 1993
32. Crook T, Vousden KH: Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanism of metastasis and involvement of environmental carcinogens. EMBO J 11:3935-3940, 1992
33. Jenkins D, Sherlaw-Johnson C, Gallivan S: Can papilloma virus testing be used to improve cervical cancer screening? Int J Cancer 65:768-773, 1996
34. Barbosa MS, Schlegel R: The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529-1532, 1989
35. Cullen AP, Reid R, Campion M, et al: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 65:606-612, 1991
36. Vernon SD, Unger ER, Miller DL, et al: Association of human papillomavirus type integration in the E2 gene with poor disease survival from cervical cancer. Int J Cancer 74:50-56, 1997
37. Romanczuk H, Howley PM: Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A 89:3159-3163, 1992
38. Couturier J, Sastre-Garau X, Schneider-Maunoury S, et al: Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol 65:4534-4538, 1991
39. Dürst M, Croce CM, Gissmann L, et al: Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A 84:1070-1074, 1987
40. Xi LF, Koutski LA, Galloway DA, et al: Genomic variation of human papillomavirus type 16 and risk for high-grade cervical intraepithelial neoplasia. J Nat Cancer Inst 89:796-802, 1997
41. Apple RJ, Becker T, Wheeler CM, et al: Comparison of human leucocyte antigen DR-DQ disease association found with cervical dysplasia and invasive cervical carcinoma. J Nat Cancer Inst 87:427-435, 1995
42. Sastre-Garau X, Loste MN, Vincent-Salomon A, et al: Decreased frequency of HLA-DRB*13 alleles in French women with HPV-positive carcinoma of the cervix. Int J Cancer 69:159-164, 1996
43. Pao CC, Hor JJ, Yang F, et al: Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis. J Clin Oncol 15:1008-1012, 1997
44. Rotman M, Pajak T, Choi K, et al: Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of ROTG 79-20. JAMA 274:387-393, 1995
45. zur Hausen H, de Villiers E: Human papillomaviruses. Annu Rev Microbiol 48:427-447, 1994
46. Chen L, Thomas EK, Hu S, et al: Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA 88:110-114, 1991